Latham & Watkins LLP represented the underwriters in the offering. Keros Therapeutics, Inc. completed its public offering of 2,600,000 shares of common stock at a price…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
